![Raf Roelands](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Raf Roelands
Director/Board Member at
Ontoforce NV
Profile
Raf Roelands is currently Director at Ontoforce NV, Director at MRM Health NV since 2020, Director at Hypervision Surgical Ltd. since 2023, and Partner at Heran Partners BV.
Former positions include Director at reMYND NV and Senior Investment Manager at Korys Management NV from 2021 to 2022.
Education includes graduate degrees from Vlerick Leuven Gent Management School in 2016 and Katholieke Universiteit Leuven in 2009.
Raf Roelands active positions
| Companies | Position | Start |
|---|---|---|
Ontoforce NV
 Ontoforce NV Packaged SoftwareTechnology Services Creates and implements pioneering technology for information flow and management | Director/Board Member | - |
MRM Health NV
 MRM Health NV BiotechnologyHealth Technology Operates biopharmaceutical company that focuses on the discovery and development of innovative therapeutics based on the human micro biome | Director/Board Member | 31/01/2020 |
Hypervision Surgical Ltd.
 Hypervision Surgical Ltd. Packaged SoftwareTechnology Services Provides AI-powered spectral imaging services of surgeries | Director/Board Member | 31/05/2023 |
Heran Partners BVBA
 Heran Partners BVBA Investment ManagersFinance Heran Partners invests in private companies located in Europe. The firm focuses on the health technology sector. It participates in seed stage, early stage and growth stage transactions with an investment size of EUR 5 - 50 million. The firm acquires minority and majority interests and makes co-investments. | Private Equity Investor | - |
Former positions of Raf Roelands
| Companies | Position | End |
|---|---|---|
Korys Management NV
 Korys Management NV Investment ManagersFinance Korys invests in companies located in Belgium. The firm focuses on conscious consumer, energy transition and healthy living sectors. It participates in buyout and early stage transactions with an investment size of EUR 5 - 15 million. The firm also makes investment in private equity funds. | Private Equity Analyst | 31/05/2019 |
reMYND NV
 reMYND NV Miscellaneous Commercial ServicesCommercial Services Engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders | Director/Board Member | - |
Training of Raf Roelands
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
79
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Korys Management NV
Korys Management NV Investment ManagersFinance Korys invests in companies located in Belgium. The firm focuses on conscious consumer, energy transition and healthy living sectors. It participates in buyout and early stage transactions with an investment size of EUR 5 - 15 million. The firm also makes investment in private equity funds. | Finance |
Katholieke Universiteit Leuven
 Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vlerick Leuven Gent Management School
 Vlerick Leuven Gent Management School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services Engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders | Commercial Services |
Ontoforce NV
Ontoforce NV Packaged SoftwareTechnology Services Creates and implements pioneering technology for information flow and management | Technology Services |
Heran Partners BVBA
Heran Partners BVBA Investment ManagersFinance Heran Partners invests in private companies located in Europe. The firm focuses on the health technology sector. It participates in seed stage, early stage and growth stage transactions with an investment size of EUR 5 - 50 million. The firm acquires minority and majority interests and makes co-investments. | Finance |
MRM Health NV
MRM Health NV BiotechnologyHealth Technology Operates biopharmaceutical company that focuses on the discovery and development of innovative therapeutics based on the human micro biome | Health Technology |
Hypervision Surgical Ltd.
Hypervision Surgical Ltd. Packaged SoftwareTechnology Services Provides AI-powered spectral imaging services of surgeries | Technology Services |
- Stock Market
- Insiders
- Raf Roelands
